Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 213, Issue 11, Pages 2399-2412
Publisher
Rockefeller University Press
Online
2016-09-26
DOI
10.1084/jem.20160258
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite–derived phospholipase
- (2016) Rachael Jarrett et al. Science Translational Medicine
- Elevated and cross-responsive CD1a-reactive T cells in bee and wasp venom allergic individuals
- (2015) Sumithra Subramaniam et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Bee venom processes human skin lipids for presentation by CD1a
- (2015) Elvire A. Bourgeois et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Melanocyte antigen triggers autoimmunity in human psoriasis
- (2015) Akiko Arakawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy and safety of brodalumab in subpopulations of patients with difficult-to-treat moderate-to-severe plaque psoriasis
- (2015) Kim Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- αβ T cell antigen receptor recognition of CD1a presenting self lipid ligands
- (2015) Richard W Birkinshaw et al. NATURE IMMUNOLOGY
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
- (2015) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guttate psoriasis is associated with an intermediate phenotype of impaired Langerhans cell migration
- (2014) L.H. Eaton et al. BRITISH JOURNAL OF DERMATOLOGY
- The plot thickens while the scope broadens: a holistic view on IL-17 in psoriasis and other inflammatory disorders
- (2014) Michael P. Schön EXPERIMENTAL DERMATOLOGY
- Cellular sources of IL-17 in psoriasis: a paradigm shift?
- (2014) Romy R. M. C. Keijsers et al. EXPERIMENTAL DERMATOLOGY
- Composition of Innate Lymphoid Cell Subsets in the Human Skin: Enrichment of NCR + ILC3 in Lesional Skin and Blood of Psoriasis Patients
- (2014) Marcel B.M. Teunissen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema
- (2014) M. Quaranta et al. Science Translational Medicine
- The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
- (2014) Roberto Lande et al. Nature Communications
- Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin
- (2013) B. Dyring-Andersen et al. BRITISH JOURNAL OF DERMATOLOGY
- Ustekinumab for the treatment of nail psoriasis in heavily treated psoriatic patients
- (2013) Magalys Vitiello et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- T cell–derived microvesicles induce mast cell production of IL-24: Relevance to inflammatory skin diseases
- (2013) Irit Shefler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment-Related Restoration of Langerhans Cell Migration in Psoriasis
- (2013) Frances L. Shaw et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Characterization of Innate Lymphoid Cells in Human Skin and Blood Demonstrates Increase of NKp44+ ILC3 in Psoriasis
- (2013) Federica Villanova et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CD1a-autoreactive T cells recognize natural skin oils that function as headless antigens
- (2013) Annemieke de Jong et al. NATURE IMMUNOLOGY
- IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation
- (2012) Anna Balato et al. EXPERIMENTAL DERMATOLOGY
- Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study
- (2012) A.B. Kimball et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
- (2011) A. M. Lin et al. JOURNAL OF IMMUNOLOGY
- Borrelia burgdorferi infection regulates CD1 expression in human cells and tissues via IL1-β
- (2010) Konstantin Yakimchuk et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire
- (2010) Annemieke de Jong et al. NATURE IMMUNOLOGY
- Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis
- (2010) Pieter C. M. Res et al. PLoS One
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Exosomes – vesicular carriers for intercellular communication
- (2009) Mikael Simons et al. CURRENT OPINION IN CELL BIOLOGY
- Exosomes: proteomic insights and diagnostic potential
- (2009) Richard J Simpson et al. Expert Review of Proteomics
- Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis
- (2009) Shinji Kagami et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin
- (2009) Lakshmi Krishnamoorthy et al. Nature Chemical Biology
- Presentation of lipid antigens to T cells
- (2008) Lucia Mori et al. IMMUNOLOGY LETTERS
- Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
- (2008) Michelle A. Lowes et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Exosome Function: From Tumor Immunology to Pathogen Biology
- (2008) Jeffrey S. Schorey et al. TRAFFIC
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started